Sarepta Therapeutics (SRPT) Total Debt Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.14% |
| Dec 31, 2025 | -3.54% |
| Sep 30, 2025 | 8.87% |
| Jun 30, 2025 | 10.42% |
| Mar 31, 2025 | 10.60% |
| Dec 31, 2024 | 10.77% |
| Sep 30, 2024 | 22.98% |
| Jun 30, 2024 | 23.26% |
| Mar 31, 2024 | 23.82% |
| Dec 31, 2023 | 24.10% |
| Sep 30, 2023 | 24.38% |
| Jun 30, 2023 | 22.97% |
| Mar 31, 2023 | 23.43% |
| Dec 31, 2022 | 29.07% |
| Sep 30, 2022 | 118.07% |
| Jun 30, 2022 | 150.25% |
| Mar 31, 2022 | 140.39% |
| Dec 31, 2021 | 132.49% |
| Sep 30, 2021 | 125.93% |
| Jun 30, 2021 | 122.12% |
| Mar 31, 2021 | 120.41% |
| Dec 31, 2020 | 116.42% |
| Sep 30, 2020 | 101.99% |
| Jun 30, 2020 | 101.78% |
| Mar 31, 2020 | 238.46% |
| Dec 31, 2019 | 236.78% |
| Sep 30, 2019 | 184.08% |
| Jun 30, 2019 | 205.45% |
| Mar 31, 2019 | 203.81% |
| Dec 31, 2018 | 108.86% |
| Sep 30, 2018 | 61.69% |
| Jun 30, 2018 | 203.30% |
| Mar 31, 2018 | 201.30% |
| Dec 31, 2017 | 200.57% |
| Mar 31, 2017 | 49.70% |
| Dec 31, 2016 | 54.37% |
| Sep 30, 2016 | 58.45% |
| Jun 30, 2016 | 60.76% |
| Dec 31, 2015 | 61.16% |